实验血液学架起实验宣与临床的桥梁——血液学的希望80Kantalji锄H，GilesF，Wunder】eL，“df．Nilotinib in imatinib— resistantCML and philadelphia chromosome—positiVeALLNEnglJMed，2006：354：2542—Ca丌D11 wL，BhojwaniD，MinDJ，“af．Pedia试c acute lymph— oblastic leukemia．HematologyAmSocHematolEducPrograrn2003；2003：102一】3l82Pui cH，EValls wE．Treatment of acute lymphoblastic leukernia．NEnglJMed，2006；354：166—Carrol】wL，BhojwaniD，MinDJ，甜日Z．PediatricAcuteLymphoblasticLeukemia．HematologyAmSocHematolEducProgram2003；2003：102～KauTR，WayJC，SilVerPA．Nuclear tmnspon and cancer：from mechanism to interventionNatRevCancer，2004；4：106一EsteyEHTherapeutic options for acute myelogenous leukeIrⅡaCancer．200l：92：1059—MecucclC．RosatiR．StarzaRL．1eukemia．RevC1inExpHemat01，Genetic pro础e of acute myeloid2002；6：3—2587LichtJD，StembergDW．The molecu】ar pathology of acute myeloidIeukemiaHematologyAmSocHematolEducPmgraHl，2005；2005：137一PLIiCH．JehaSNew therapeutic strategies forche treatment of acute lymphoblasticIeukaenlia．NatReVDrugDiscoV，2007；6：149一ZhouGB，ZhangJ，WangZY，订础．Treatment of acute promye一10cytic leukaemia with a11一trans retinoic acid and arsenic trioxide：a paradigm of synergistic molecular targeting therapy．PhilosTransRSocLondBBioISci2007；362：959—ZhouGB，ChenSJ，ChenZ．Acute promyelocytic leukemia：a model of molecular target based ther印y．Hematology，2005；1O(SupplI)：270—2809lDouerD，Preston—Manin s，changE，“以Z．H唔h fI．equency of acute promyelocyticJeukemia aITlongLatinos with acute myeloid leukemiaBlood．1996；87：308—teroJc， santillana s，FereyrosG．Hi曲f嘲uency of acute promyelocytic1eukemia amongLatinos with acute myeloid leukemiaB100d．1996；88：TomasJF，Femandez—RanadaJM．About the increased行equency of acute promyelocytic leukemia amongLatin08： the experience from a center inSpain．BIood，1996；88：2357—RowleyJD．GolombHM，DoughenyC15／17 tmnslocation，a consistent chromosomal change in acute pmmyelocytic leukaemia．Lancet，1977；l(8010)：549— de—TheH．ChomienneC，LanotteM，Pf甜The t(15；17) translOcation of acute promyelocytic1eukaemia t’uses the retinoic acid receptor alpha gene to a noVel transcribed10cus．Nature，1990：347(6293)：558—KaJ(izukaA．MillerWH．Jr．UmesonoK，“以Z．Chromosomal trallslocationI(15；l7) in human acute promyelocytic leukemia fusesRAR alpha witll a novel putative tmnscription factor，PMLCell．1991：66：663—MelnickA，LichtJDDeconstructing a disease：RARalpha，its fusion pa咖ers， and their r01es in山e pathogenesis of acute pmmye】ocytic1eukellliaBIood，1999；93：3167—ChenSJ，ZelentA，TongⅢ，甜甜．Rearrallgements ofthe retinoic acid receptor alpha and pmmyelocytic leukemia zinc finger genes resulting t-Tom t(1l；17)(q23；q21)in a patient with acute promyelocytic leukemia．JC1inInVest，1993；9l：2260—ChenZ，GuidezF，ROusselotP，Pf dZPLZF—RAR alpha fhsion proteins generated from theVariaIlt t(11；17)(q23；q21) translocation in acute promyelocytic leukelllia inhibit1幢and— dependent tfansac“Vation of wild—type retinoic acid佗ceptors．ProcNatlAcadSciUSA．1994；91：1178一ChenZ，BralldNJ，ChenA，甜口f．Fusion between a novelKruppel—like zinc nnger gene and也e re“noic acid receptor-alpha10cus due to a v撕ant t(11；17)trallslocation associated with acute promyelocytic leukaemia．EM：BOJ，1993；12：116l—lZhangT，XiongH，KanLX，ef nf．Genomic sequence，stmctural o唱anization，m01ecular eV01ution，a11d abe嗽nt rearrangement of pmmyelocytic leukemia zinc finger gene．ProcNatlAcadSciUSA，1999；96：—ChengGX，ZhuXH，MenXQ，甜们Djstinct leukemia phenotypes in transgenic mice aIld difhent corepressor interactions generated by promyelocytic1eukemiaVariaI】t fusion genesPLZF-RARalpha andNPM—RARalpha．ProcNatlAcadSciUSA，1999；—CoreySJ，LockerJ，OliVeriDR，甜口，．A non—classical trans— location inVolVing17q12(reⅡnoic acid receptor alpha)in acute promyelocytic leukemia(APM吐) with atypical featuresLeukemia．1994：8：1350一WellsRA．HummelJL，De—KovenKA， translocation in acute pmmyelocytic“以Z．A leukaeIIlia： neWVanant mOIecular ch锄cterization aIld clinical conelationLeukerIlia，】996；10：735—HuangME，YeYC，ChenSR，“以A11一虹ans retinoic acid witll or withoutIow dose cytosine arabinoside in acute promyelocytic leukemia．Report of6 cases．chinMedJ(En91)．1987；100：949—HuangSL，GuOAX，XiangY，“口f．Clinjcal study on the treatment of acute pmmyelocytic leukemia withCompositeIndigoNaturalis tablets．ChinJHemat01，1995；16：26—NiuC，YanH，YuT，甜酬．Studies on treatment of acute promyelocytic1eukemia with arsenic trioxide： remission induction， f01low—up， and molecular monitoring in11 newly diagnosed and47 relapsed acute promyelocytic leukernia patients．Blood．1999：94：3315—ZhangP，WangSY，HuLH acute pmmyelocytic1eukemiaArsenic trioxide treated72 cases ofChinJHemat01，1996：17：58—ShenZX，ChenGQ．NiⅢ，盯酬．Use of arsenic trioxide(A8203) in the treatment of acute promyelocytic leukemja(APL)：II．C1inical emcacy and phanllacokinetics in relapsed p atjentsB100d，1997；89：3354—Sun皿，MaL，HuXC，酣Ⅱ，．Ai—LinI treated32 cases of acute pmmyelocytic】eukemia．ChinJIntegratChinWestMed．I992；12．170—MervisJAncient remedy pe怕ms new砸cks．Science，(5275)：LiuYF，ZhuYM，ShenSH，甜以f．Mo】ecular response in acute promyelocytic leukemia：a direct comparison of regular a11d real‘ timeRT．PCR．Leukemia．2006：20：1393—LiuYF，ZhuYM，ShiZZ，甜Ⅱ，Long—tenTl fbllow—up confirms the beneflt of a11-trans retinoic acid(ATRA)and arsenic trioxide(As203) as f如nt1ine therapy fbr newly diagnosed acute promyelocytic leukefnia．Blood，2006；108：l70a(abstmct565)114ShenZX，ShiZZ，FangJ．甜以Z．All—trans retinoic acid／A5203 combination yieIds a high quality relllission and surviVal in newly diagnosed acute promyelocytic1eukemiaProcNatlAcadSciUSA，2004：10l：5328—DegosLThe histOry of acute promyelocytic leukaemia．BrJHaematol，2003；122：539—HillestadLKAcute promyelOcytic leukeIIlia．ActaMedScalld，1957；159：189—DraphnRL，GeeTs，DowlingMD，甜以Prophylactic h印arin therapy in acute pmmyelocytic1eukemia．Cancer，1978；41：2484—BemardJ，WeilM，BoironM，ef“f．Acute pmmyelocytic leukemia：results()t t陀atment by daunorubicinBlood，1973；4l：489—TallmallMS，NabhanC，FeusnerⅢ，甜“．Acute promyelocytic leul(e111ia：eV01Ving t11erapeutic s岫舱gies．B100d，20【)2；99：759—SlackJL，WaxmanS，TricotG．甜讲．Advances in the management of acute pmmyelocytic leukemia and other hemat0109ic malignancies wim arsenic trioxideOncologist，2002；7(Suppj1)：l—ChanKW，SteinherzPG，M川erDR．Acute promyelocytic leukemia in childremMedPediatr oncol，198l：9：5—CordollllierC，VemalltJP，BrunB，甜以f．Acute pmmyelocyⅡcIeukernia in57 preViously un廿eated pmients．Callcer，1985；55：18—25 l23KantaIjianHM．KeatingMJ，WaltersRS，甜以Acute pmmyel—Ocytic leukemiaM．D．AndersonHospital experience．AmJMed，1986：80：789—SallzMA，Jarque l，ManinG，d以f．Acute pmmyelocytic1euke—111ia．Therapy results and prognostic f沁torsCallcer1988；6l：7— sachsL control of nonllal cell differentiation and the phenotypic reVersion of malignancy in myeloid1eukaemia．Nature，1978；274-535—Hofhnan—LiebemannB．SachsL proteins in the difkrentiationOf1978：14：825—834RegulatiOn of actin aIldOther myelOid1eukemic cells．Cell，127LotemJ．SachsL m v如D induction of no丌11al dif艳rentiation in myeloid1eukemia cellsProcNatlAcadScjUSA．1978；75：378l一BreitmanTR．SeIonickSE．CollinsSJInduction of differen． tiation of the human pmmyelocytic1eukemia cell une(HL_60)by retinoic acid．ProcNatlAcadSciUSA，1980；77：2936—BreitmanTR．CollinsSJ．KeeneBRTemlinal difkrentiation of human pronlyelocytic1eukemic ce¨s in primary cuJture in response to retinoic acid．Blood，198l；57：1000—F1ynnPJ，MillerWJ，WeisdorfDJ，“nf．Retinoic acid treatment of acute promyelocytic1eukemia：加 v打m and抽 v如D obserVations．B100d，1983：62：121l—lF0ntanaJA，RogersJS，DurhamJP．The mle of13 cis—retinoic acid in山e remission induction of a patient wjth acute promyelocytic leukemia．Cancer，1986；57：209—NilssonBPmbable加VfVD induction of differentiation by retinoic acidOf pmmyelocytes in acute pmmyelocytic leukaemia．BrJHaematOl，1984；57：365—RundeV，AulC，SudhoffT，甜ⅡZ．RetinOic acid in the treatment中国实验血液学杂志，E甲胁优n加z2008；16(1) of acute promyelocytic leukemia： inemcacy of山e13一cis isomer and induction of complete remission by山e a11一trans isomer complicated by山romboemb01ic eVents．AnnHemat01，1992；64：270一WarrellRPJr．de—TheH．1eukemia．NEn91JMed，WangZY，甜酬．Acute promyelocytic1993；329：177—Slack几．WaxmanS．TricotG．订ⅡfAdv arIces in山e man— agement of acute pmmyelocytic leukemia and other hematologic malignancies with arsenic moxide．Onc0109ist，2002；7：l一WaIlgZYHam—Wasse丌nan lecture：treatment of acute leukemia by inducing differentiation a11d apoptosisHematolOgyAmSocHematolEducProgram，2003：1—13 l37NerViC，FerraraFF，FanelliM，甜n1．Caspases medi ate retinoic acid—induced degradationOf the acute promyelocytic leukemiaPML／RARalpha t’usion protein．Blood1998；92：2244—225 l138ZhuJ，GiallniM，KopfE，甜“f．Retinoic acid induces proteasome—dependent degradation of retinoic acid receptor ajpha(RARalpha)and oncogenicRARalpha fusion pmteins．ProcNatlAcadSciUSA．1999：96：—KitareewanS．PⅢ1a—RoweI．SekulaD．甜以，．UBElL is a retinoid target that triggersPML／RARalpha degradation and apoptO如s in acute promyeIocytic leukemia．ProcNatlAcadSciUSA，2002：99：3806—38Il140TylerJK，Kadonaga几．The“dark side”of chromatin remo— deling：repressiVe eft色cts on transcription．Cell，】999；99：443—lLinRJ，NagyL，InoueS，订口， complex in acute promyelocytic(6669)：81】一814Role of the histone deacetylase eukaemia．Nature．1998：GrignaniF，De·MatteisS，NerviC，甜n，．Fu sjon proteins of tbe retinoic acid recepto卜alpha recn】it histone deacetylase in promyelocytic leukaemia．Nature，1998；391(6669)：815—GuidezF，IvinsS，ZhuJ．“Ⅱf．Reduced retinOic acid—sensi— tiVities of nuclear receptOr corepT℃ssor binding toPML—andPLZF—RARalpha underlie molecular pathogenesis a11d treatment of acute promyelocytic1eukemiaBlood，1998；9 l：2634— wangJ，SaunthararajallY，RednerRL，P，d，．Inhibitors of histone deacetyIase relieVeETO—mediated repression and induce dif-ferentiation ofAMLl_ETo1eukemia cellsCancerRes．1999：59．2766—WaxmanS．Differentiation therapy in acute myeIogenous leukemia(non—APL)Leukemia，2000：J4：491—ZhengPz，wangKK，ZhangQY，P，以fSystems analysis of transcriptome and proteome in retinOic acid／arsenic moxide— induced cel|diff色rentiatioll／apoptosjs of promye】ocytic leukemia．ProcNatlAcadSciUSA，2005：102：7653—MaoM，YuM，TongJH，出以，RIG—E，a human hom0109 ofthe munneLy_6 famjly， is induced by retinoic acid during the diff色rentiatiOnOf acute prOmyelocytic1eukemia cell．ProcNat】AcadSciUSA，1996；93：5910—YuM，TongJH，MaoM，Pr以Z．C10ning of a gene(RIG—G) associated with r℃tinoic acid—induced dif佗rentiation of acute promye—locytic leukemia cells and representing a new member of a family of inte他ron—stimulated genes．PmcNaclAcadSclUSA，1997；94：7406—741 l149 xiaoS，LjD，ZhuHQ，“nZ．RIG—G as a key mediator o“he antipmliferatiVe actiVity of inle盹ron—related pathways thmu曲实验血液学架起实验室与临床的桥梁——血液学的希望 enhancing p2I and p27 pmteins．ProcNatlAcadSciUSA，：一KiniAR．PetersonLA，TallmanMS，甜甜Angiogenesis in acute promyelocytic1eukemia：induction byVascular endothelial gmwth factor and inhibition by a11一trans retinoic acidBlood，2001：97：3919—3924StreuliCExtracellular matrix remodelling and cellular differen tia“onCurr opinCellBiol，1999；ll：634—CharradRS，LiY，DelpechB，甜Ⅱf．Ligation of theCI)44 adhesion molecule reVerses blockageOf dif话rentiation in humall acute myeloid leukemia．NatMed，1999；5：669—硒ncadePW．Blasting away leukemla．NatMed，1999；5：619—ZhuQ，ZhangJw，ZhuHQ，甜n，．Synergic efkcts of arsenicⅢoxide and cAMP during acute pmmyelocytic leukemia cell maturation subtends a noVel signaling cross—talkBlood2002；99： lOl4—KamasheVD，VitouxD，de—TheH．PML—RARA—RXR01igomers mediate retinoid and rexinoid／cAMP cross—ta】k in acute pmmyelo— cytic leukemia cell difllerentiationJExpMed，2004；199：1163一 lJChelbi—A1ixMK．PelicanoL1ing cmss talk in nomlal and1999：13：1167一1174Retinoic acjd a11d interfemn signaRA—resistantAPL cells．Leukemia157LippmanSM，LotanR，SchIeunigerURetinoid．interferon the． rapy of soIid tumors．IntJCancer，1997；70：48l一ZhuJ，ChenZ，Lallemand—BreitenbachV．订酬．How acute promye— locytic1eukaemia revived arsenic．NatRevCancer．2002；2：705—ZhuJ，LalJemand—BreitenbachV，de—TH．Pathways of retinoic acid—or arsenic trioxide—inducedPML／RARalpha catabolism，role of oncogene degradation in disease remissionOncogene，2001；20：7257— zhuJ，KokenMH，Quignon targe—ting onto nuclear bodies acute promyelocytic1eukemia．94：3978—3983F．Ff nf．Arsenic．inducedPML implicatiOns t10r me“℃atment ofPmcNatlAcadSciUSA．】997：16lIshoVAM，SotnlkovAG，NegorevD，“以Z．PML is critical forNDlO fbnnation and rec nIits thePML-interacting protein daxx to this nuclear structure when modjned bySUMo—1．JCellBi01．1999：】47：22l一MannKK．Mi】lerWHJr sumoylationCancerCell，Death by arsenic：implications ofPML2004：5：307—MillerWHJr，SchipperHM，LeeJS，“ⅡZ．Mechallisms of action of arsenic moxideCancerRes，2002；62：3893—LazoG，KantarjianH，EsIeyE，甜以，Use of arsenic tnoxide(A82 oj) in che treacmeⅢof patients with acute pmmyeJocytic leukemia：theM．D．Anderson experience．Cancer，2003；97：2218—SoignetSL，FrankelSR，DouerD，Pf以Z．UnitedStates multi． center study of arsenic triOxide in relapsed acute promyelocytic1eukemia．JC1in onc01，2001；19：3852—JingY，WangL，xiaL，“以Combined ef诧ct of a11．tmns retinoic acid and arsenic trioxide in acute promyelocytic1eukeIIlia cells in v打，订and in vivD．B100d，200l：97：264—EsteyE，Garcia—ManemG，Ferrai01iA，甜ⅡZ．Use of all—trans retinoic acid plus arsenic砸oXide as aI】altemative to chemotherapy in untreated acute pmmyelocytic leuke仃lia．B100d，2006；107：3469—WallgG，LiW，CuiJ，甜以An emcient therapeutic approach to patients with acute pmmyelocytic1eukemia using a combination of arsenic moxide wi山10w—dose a11一trans retinoic acid．Hemat01 onc01，2004；22：63—71 l69Lo。CocoF，CiHⅡnoG，BrecciaM，甜以f．Gemtuzumab ozoga． micin(Mylotarg)as a single agent for moleculady relapsed acute promyelocytic leukemja．B100d，2004；104：1995—JurcicJG，DeBlasioT，DumontL，甜酬．M01ecular remission induction wi山retinoic acid and anti—CI)33 monoclonal antibodvHuMl95 in acute promyelocytic leukeIIlia．C1inCaIlcerRes，2000；6：372—SohalJ，PhanVT，ChanPV．已f nf．A model ofAPL withFLT3 mutation is responsiVe to retinoic acid and a receptor tymsine1(inase inhjbitor，SUll657Blood，2003；101：3188—LichtJD．AMLl a11d山eAMLl一ETo fhsion pmtein in the pathogenesis of t(8；21)AMLOncogene，2001；20：5660一5679 l73RubnitzJE，RaimondiSC．HalbertAR．甜nf．Characteristics and outcome of t(8；21)·positiVe chjldhood acute myeIoid leukemia：a sin91e institution’s experience．I。eukemia，2002；16：2072—MiyagiJ．KakazuN，MasudaM，甜以Acute myeloid leukemia(FAB一Ⅳ您)wim a masked type oft(8；21)translocation revealed by spectral karyotyping．IntJHematol，2002；76：338—GamerdingerU，Tei91e卜SchlegelA，PilsS，“以Cryptic c11romo— somal abemtions leading to anAMLl／ETO rearrangement are frequently caused by small insertions．GenesChmmosomesCancer，2003；36：261—NissonPE，WathnsPC，SaccMN．Trallscriptionally active chimeric gene deriVed f如m the fusion of t11eAMLl gene and a noVel gene on chmmosome8 in t(8；21)leukemic cells．CancerGenetCytogenet，1992；63：81—E^cksonP，GaoJ，ChangKS，Pf“Z．Identi行cation of breakpoints in t(8；21)acute myelogenous leukeIIlia aIld isolation of a fusion transcript，AMLl／ETO， wittI sim们arity toDmsophila segmentation gene，nInt．B100d，1992；80：1825—MiyoshiH，shimizuK，KozuT，“以f．t(8；21)breakpoints on chmmosome2 l in acute myeIoid leukemia are clustered within a1imited region of a single gene，AMLlProcNatlAcadSciUSA，199I：88：1043l一ShimizuK，MiyoshiH，KozuT，甜ⅡZ．Consistent disnIption of theAMLl gene occurs within a single intmn in the t(8；21) chmmosomal translocation．CaJlcerRes，1992；52：6945—HiebenSW，LutterbachB，AmannJ．Role of co—repressors inⅡ仙s criptionalI℃pression mediated by吐le t(8；21)，t(16；21)，t(12；21) aIld inV(16)fusion pmteins．currOpinHemaf01，200l；8：197—AmannJM，NipJ，StromDK，“Ⅱf．ETO，a target or t(8；2】) in acute leukemia， makes distinct contacts with mu】tiple histone deacetylases and binds mSin3A mrDugh its01igomedza廿on domain．MolCellBiol，2001：21：6470—PabstT，MueUerBU．HarakawaN，甜“fAMLl一ETO down— regulates the granulocytic di】=!fbrentiation tIactorC／EBPalpha in t(8；21)myeloid leukeIuia．NatMed，2001；7：444—45l183VangalaRK，Heiss—Neum arInMS，RangatiaJS，甜以ZThe mye一10id master regulator transcription factorPU．1 is inactivated byAMLl—ETo in t(8；21)myeloid leukemia．Blood，2003；10l：270一277 l84JakubowiakA，PouponnotC，BerguidoF，已f nfInhibition of the transfomling growm factor beta l s培naling pathway by theAMLl／ETO1eukemia—associated fusion protein．JBi01Chem，2000：275：—Lin991B，Mulle卜Tidow c，van—deLochtL，Pf以Z．The t(8；21) fusion pmtein，AMLlETo，specmcaIly represses the trfmscription of the p14(ARF)tumor suppressor in acute myeloid leukemia-NatMed．2002；8：743—KlampferL，ZhangJ，zeIenetzAO，er“TheAMLl／ETo fusion pmtein activates crallscription ofBCL一2ProcNatlAcadSciUSA．1996：93：一E1sasserA，FranzenM，KohlmallnA，订nf．The fusion pmteinAMLl．ETo in acute myeloid leuke皿a with tmnslocation t(8；21) induces c_jun pmtein expression v胁the pmximalAP一1 site of the c_jun promoter in an indirect，JNK—dependent mannerOncogene，2003：22：5646—ShimizuK，Kitabayas|liI，K锄adaN，甜df．AM【L1一～r11G8 leuke‘ mic protein induces山e expression of gr锄ulocyte c010ny—stimulating factor(G—csF)receptor t11mu曲the up—regul撕on of ccAA7I'／ enhaJlcer binding pr()tein印silon．B100d，20()o；96：288—HildebrandD，TiefenbachJ，HeinzelT，甜酬Multiple regions ofETo cOoperate in transcriptiOnal rcpressiOn·JBiolChem，2()()1；276．9889—MulloyJC，CammengaJ，MacKenzieKL，“以Z．TheAMLl一ETo t'usion protein promotes山e expansion of human hematopoietjc stem cells．Blood，2002；99：15—TonksA，PeamL，TonksAJ，甜以f．TheAMI，l—ETo fusion gene pmmotes extensive selt’_renewal of human primary erythroid cells．Blood．2()03；10l： de—GuzmanCG，Warr℃nAJ，ZhangZ，甜以，．Hematopoietic stem cell expansion aJld distinct myeloid deVelopmental abno衄alities in a murine model of theAMLl—ETo translOcatiOn．MOlCellBi01．20()2：22：5506—YergeauDA，HetheringtonCJ，WangQ，町Ⅱf．Embryonic1e山a— lity and impaiment of haematopoiesis in mice heterozygous t’or anAMLl一ETo fusion gene．NatGenet，1997；15：303—kudaT，CaiZ，YangS，已r df．Expression of a knocked—inAMLl一ETo1eukernja gene inhibits the establishment of nonTlal definitiVe hematopoiesis aJld directly generates dysplastic hemato— poietic progenitors．Blood，1998；91：3134—BuchholzF，Ret’aeljY，TmmppA，甜耐．Inducible chromosomal translocation ofAMLl andETO genes thmughCre／IoxP—mediated recombination in ttle mouse．EMBORep，2000；l：133一HiguchiM，0’BrienD，KumaraVeluP，甜甜．Expression of a conditionalAMLl一ETo oncogene bypasses embryonic lethality and establishes a murine model of humall t(8；21) acute myeloid1eukemiaCancerCell．2002：1：63—RhoadesKL．HetheringtonCJ．Ha如kawaN，酣Ⅱ，．Analysis of the role ofAMLl—ETo in leukemogenesis， using an inducible transgenic mouse model．B100d，2000；96：2108—MulloyJC，CaIllmengaJ，BerguidoFJ，“以Maintaining the self_renewal aJld di仟erentiation potential of humanCD34+ hemato—poietic cells using a sin91e genetic e】ement．Blood，2003；102．4369—YuanY，ZhouL，MiyamotoT，P，口Z．AMLl—ET0 expression is directly involved ln the developmentOf acute myeloid1eukemia in中国实验血液学杂志，￡甲HPm以幻f2008；16(1) the presence of additiOnal mutations．PmcNatlAcadSciUSA2001：98：一l()CarrollM．TomassonMH，BarkerGF，以以，．TheTEL／platelet— derived gmwth f-actor beta receptor(PDGF betaR) t、usion in chronic mvelomonocytic leukemia is a transtomllng proteln that self-associates a11d activatesPDGF betaR kinase—dependent sIgna一1ing pathways．ProcNatlAcadSciUSA，1996；93：一YanM．BurelSA，PetersonLF，P，d，Deletion of anAMLl—ETOC—tenninalNcoR／SMRT—interacting region strongly induces leukemia development．ProcNatlAcadSciUSA，2(m4；10l：—1719l202Sakal(umC，Yamaguchi—1waiY，Satal(eM，甜df．Gmwth inhibi— tion and induction of d¨krentiation of t(8；21) acute myeloid leukemia cells by theDNA—binding domain ofPEBP2 and theAMLl／MTG8(ETo)一specinc antisense oligonucleotide．PmcNatlAcadSciUSA．1994：9l：—MatsushitaH，KobayashiH，MoriS，甜n!Ribozymes cleaVe theAMLl／MTG8 fusion franscript and inhibit pr01iferation of leukemic cells with t(8；21)BiochemBiophysRcsCommun，】995：215：431—4372【)4MatsushitaH，KizakiM，KobayashiH，“以f．Induction of apOptosis in myelo|d leukaemic cells by ribozymes targeted againstAMLl／MTG8BrJCancer．1999：79：1325一Heidenreich o．KrauterJ．RiehleH．甜“Z．AMLl／MT(摁Onco— gene suppression by sma“ interferingRNAs supports myeloid dif诧ren“ation of t(8；21)一posiciVe leukemic cellsBlood，2【)()3；101：3157—Da—SilraN，Meye卜MonardS，MenotML，已，以，．FunctionalG—CSF pathways in t(8；21)Ieukernjc ceIls allow for differentiat呈on induction and degradation ofAML】一ET0HematolJ，20()O；1：316—RednerRL，WangJ，LiuJM．Chmmatin remodeling and1euk emla：new thempeuIic paradigmsB100d1999；94：417—FerraraFF，FaziF，BiallchiniA，订ⅡfH商one deacetylase— targeted treatment restores retinoic acid signaling and differentiation in acute myeloid leukemiaCancerRes，200l；61：2—7209DrukerBJ．TalpazM，RestaDJ．e“lf．Emcacy and safety of a specific inhibitor of theBCR—ABL tyrosine kinase in chronic myeloid leukemia．NEnglJMed，200l；344：103I—DrukerBJ，sawyersCL，KanlarjjanH，甜以f．ActiVity of a specmc inhibitor of theBCR—ABL tyrosine kjnase in the blast crisis of chmnic myeloid leukemia and acute lymphoblastic leukemia with thePhiladelphia chmmosome．NEn91JMed，2001：344：1038一PeggsK，MackinnonSImatinib mesylate—the new gold standard for treatment of chronic myeloid1eukemia．NEn91JMed，2003；348：1048— o7BrienSG，GuilhotF，LarsonRA，订df．Imannib compared with intemmn and10w—dose cytarabine t、or newly diagnosed chIDnic—phase chmnic myeloid leukemia．NEnglJMed，20()3；348：994—KerkelaR，GrazetteL．YacobiR．订ⅡfCardiotoxiclty of the caJlcer therapeutic agent imatinib mesylate．NatMed，2006；12：908—YinT，WuYL，SunHP，盯Ⅱ，．Combined efkcts ofA84S4 and imatinib on chronic mveloidJeukemia ce】ls andBCR—ABL oncopmtein．B100d，2()04；104：4219—4225

文章来源：《中国实验血液学杂志》 网址: http://www.zgsyxyxzz.cn/qikandaodu/2021/0709/673.html